CUBT vs REGN: Which Stock is Better?

Side-by-side comparison of Curative Biotechnology Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

CUBT

Curative Biotechnology Inc

$0.01

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricCUBTREGNWinner
Market Cap$6.54M$77.77BREGN
P/E RatioN/A17.58REGN
EPS (TTM)$N/A$41.75REGN
Revenue Growth0.0%0.0%REGN
Gross Margin75.7%45.8%CUBT

Analyze CUBT

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is CUBT or REGN a better investment?

Comparing CUBT and REGN: Curative Biotechnology Inc has a market cap of $6.54M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between CUBT and REGN?

CUBT (Curative Biotechnology Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: CUBT or REGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: CUBT or REGN?

REGN has higher revenue growth at 0.0% vs 0.0% for CUBT.

Which company is more profitable: CUBT or REGN?

Curative Biotechnology Inc (CUBT) has higher gross margins at 75.7% compared to 45.8% for REGN.

Which is the larger company: CUBT or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $6.54M for CUBT.

Should I buy CUBT or REGN in 2026?

Both CUBT and REGN have investment merit. CUBT trades at $0.01 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between CUBT and REGN stock?

Key differences: Market Cap ($6.54M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (75.7% vs 45.8%).

Popular Stock Comparisons